Loading…
Discovery of cisplatin-binding proteins by competitive cysteinome profiling
Cisplatin is a widely used cancer metallodrug that induces cytotoxicity by targeting DNA and chelating cysteines in proteins. Here we applied a competitive activity-based protein profiling strategy to identify cisplatin-binding cysteines in cancer proteomes. A novel cisplatin target, MetAP1, was ide...
Saved in:
Published in: | RSC chemical biology 2023-08, Vol.4 (9), p.67-674 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cisplatin is a widely used cancer metallodrug that induces cytotoxicity by targeting DNA and chelating cysteines in proteins. Here we applied a competitive activity-based protein profiling strategy to identify cisplatin-binding cysteines in cancer proteomes. A novel cisplatin target, MetAP1, was identified and functionally validated to contribute to cisplatin's cytotoxicity.
A competitive activity-based protein profiling strategy was developed to identify cisplatin-binding cysteines in MCF-7 proteomes, among which cisplatin-binding sites in GLRX1, TXNDC17 and MetAP1 were biochemically verified. |
---|---|
ISSN: | 2633-0679 2633-0679 |
DOI: | 10.1039/d3cb00042g |